Lv1
98 积分 2026-03-15 加入
P3.18.46 Ivonescimab Plus Platinum-Doublet Chemotherapy as First-Line Therapy for Locally Advanced/Metastatic SMARCA4-Deficient NSCLC
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Integration of an imbalance framework with novel high-generalizable classifiers for radiomics-based distant metastases prediction of advanced nasopharyngeal carcinoma
1个月前
已完结
Deep Learning-Based Computed Tomography Perfusion Mapping (DL-CTPM) for Pulmonary CT-to-Perfusion Translation
1个月前
已完结
Automatic planning for functional lung avoidance radiotherapy based on function-guided beam angle selection and plan optimization
1个月前
已完结
Clinical experience with epinastine in patients with seasonal allergic conjunctivitis in ophthalmological practice
2个月前
已关闭
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
2个月前
已完结
Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer
2个月前
已完结
Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society
2个月前
已完结
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
2个月前
已完结
皖公网安备34019202002308
